5 February 2021
Marlowe plc
Issue of Equity and Director/PDMR Shareholding
Marlowe plc ("Marlowe" or the "Group"), the UK leader in business critical services and software which assure safety and regulatory compliance announces that, pursuant to redemptions of all remaining historical awards under the Marlowe 2016 Incentive Scheme (the "2016 Scheme"), application has been made for 2,062,647 new ordinary shares of 50 pence each in the Group ("New Ordinary Shares") to be admitted to trading on AIM. As a result, the 2016 Scheme is now settled in full and no further new ordinary shares in the Group will be issued under it.
The New Ordinary Shares, issued at an effective issue price of 615 pence per New Ordinary Share, will rank pari-passu with existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 10 February 2021 ("Admission").
1,559,669 of the New Ordinary Shares have been issued to Alex Dacre, the Group's Chief Executive Officer, and 337,928 of the New Ordinary Shares have been issued to Charles Skinner, a Non-Executive Director of the Group. Messrs. Dacre and Skinner are therefore now beneficially interested in 5,094,352 Marlowe ordinary shares (representing c.8.2 per cent. of the Group's issued share capital) and 805,084 Marlowe ordinary shares (representing c.1.3 per cent. of the Group's issued share capital) respectively.
Following Admission of the New Ordinary Shares, the Group's issued ordinary share capital will comprise 62,477,095 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 62,477,095. The above figure of 62,477,095 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
The notifications below, made in accordance with the Market Abuse Regulation, provide further details.
For further information:
Marlowe plc |
www.marloweplc.com |
Alex Dacre, Chief Executive |
Tel: +44 (0) 203 841 6194 |
Mark Adams, Group Finance Director |
IR@marloweplc.com |
|
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) |
|
Nicholas Wells |
Tel: +44 (0)20 7397 8900 |
Ben Jeynes
|
|
Joh. Berenberg, Gossler & Co. KG, London Branch (Joint Broker) |
|
Ben Wright |
Tel: +44 (0)20 3207 7800 |
Mark Whitmore |
|
|
|
FTI Consulting |
|
Nick Hasell |
Tel: +44 (0)20 3727 1340 |
Alex Le May |
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||
a) |
Name |
1. Alex Dacre 2. Charles Skinner |
|||
2 |
Reason for the notification |
||||
a) |
Position/status |
1. Chief Executive Officer 2. Non-Executive Director |
|||
b) |
Initial notification /Amendment |
Initial notification |
|||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a) |
Name |
Marlowe plc |
|||
b) |
LEI |
213800ZWSR4SBOM6B608 |
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 50 pence each |
|||
Identification code |
ISIN: GB00BD8SLV43 |
||||
b) |
Nature of the transaction |
Issue of ordinary shares pursuant to Marlowe 2016 Incentive Scheme |
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
1. 615 pence
2. 615 pence |
1. 1,559,669
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
- Aggregated volume |
Single transactions |
||||
- Price |
|
||||
e) |
Date of the transaction |
4 February 2021 |
|||
f) |
Place of the transaction |
Outside a trading venue |